Influence of microtubule-associated proteins on the differential effects of paclitaxel and docetaxel

被引:39
作者
Fromes, Y
Gounon, P
Veitia, R
Bissery, MC
Fellous, A
机构
[1] INST PASTEUR, F-75724 PARIS 15, FRANCE
[2] RHONE POULENC RORER SA, F-94403 VITRY SUR SEINE, FRANCE
来源
JOURNAL OF PROTEIN CHEMISTRY | 1996年 / 15卷 / 04期
关键词
microtubule-associated proteins; MAP2; Tau; paclitaxel; docetaxel;
D O I
10.1007/BF01886864
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Microtubules are complex structures arising in part from the polymerization of tubulin dimers. Tubulin binds to a wide range of drugs which have been used as probes for tubulin conformation and assembly properties. There is some evidence that taxol and taxotere have differing effects on tubulin conformation. Previous work has shown that MAP2 and Tau, although they both induce microtubule assembly, have qualitatively different effects on tubulin's behavior. Since most microtubules in vivo are likely to be associated with MAPs, we decided to characterize the differential effects of MAP2, Tau, taxol, and taxotere on tubulin polymerization with the aim of understanding the mechanisms through which these agents stimulate microtubule assembly. Furthermore, the inhibitive effect of calcium has been used to elucidate the ability of the two drugs to force tubulin assembly. These observations suggest that docetaxel, in addition to its greater efficiency in tubulin assembly, may have the capacity to differently alter certain classes of microtubules. Tau and MAP2 accessory proteins may represent important cofactors modulating the effects of taxoids.
引用
收藏
页码:377 / 388
页数:12
相关论文
共 42 条
[1]  
ALBERTINI DF, 1984, EUR J CELL BIOL, V33, P134
[2]  
ANDREU JM, 1994, J BIOL CHEM, V269, P31785
[3]  
BISSERY MC, 1991, CANCER RES, V51, P4845
[4]  
BISSERY MC, 1995, ANTI-CANCER DRUG, V6, P1
[5]   PHASE-II STUDY OF TAXOL, MERBARONE, AND PIROXANTRONE IN STAGE-IV NON-SMALL-CELL LUNG-CANCER - THE EASTERN COOPERATIVE ONCOLOGY GROUP RESULTS [J].
CHANG, AY ;
KIM, K ;
GLICK, J ;
ANDERSON, T ;
KARP, D ;
JOHNSON, D .
JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1993, 85 (05) :388-394
[6]  
DELATORRE J, 1986, EUR J CELL BIOL, V40, P233
[7]   AN IMPROVED SYNTHESIS OF THE TAXOL SIDE-CHAIN AND OF RP-56976 [J].
DENIS, JN ;
CORREA, A ;
GREENE, AE .
JOURNAL OF ORGANIC CHEMISTRY, 1990, 55 (06) :1957-1959
[8]   ASSEMBLY OF PURIFIED GDP TUBULIN INTO MICROTUBULES INDUCED BY TAXOL AND TAXOTERE - REVERSIBILITY, LIGAND STOICHIOMETRY, AND COMPETITION [J].
DIAZ, JF ;
ANDREU, JM .
BIOCHEMISTRY, 1993, 32 (11) :2747-2755
[9]  
DYE RB, 1993, J BIOL CHEM, V268, P6847
[10]   PHASE-II STUDY AND LONG-TERM FOLLOW-UP OF PATIENTS TREATED WITH TAXOL FOR ADVANCED OVARIAN ADENOCARCINOMA [J].
EINZIG, AI ;
WIERNIK, PH ;
SASLOFF, J ;
RUNOWICZ, CD ;
GOLDBERG, GL .
JOURNAL OF CLINICAL ONCOLOGY, 1992, 10 (11) :1748-1753